NovoCure Ltd Insider Trading for August 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd for August 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 30 2018 | NVCR | NovoCure Ltd | Palti Yoram | Chief Technology Of ... | Sell | S | 40.27 | 4,334 | 174,549 | 1,041,054 | 1 M to 1 M (-0.41 %) |
| Aug 28 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 40.03 | 9,973 | 399,203 | 37,124 | 47.1 K to 37.1 K (-21.18 %) |
| Aug 28 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 40.05 | 100 | 4,005 | 47,097 | 47.2 K to 47.1 K (-0.21 %) |
| Aug 28 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 40.03 | 200 | 8,005 | 47,197 | 47.4 K to 47.2 K (-0.42 %) |
| Aug 28 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 40.00 | 25,274 | 1,010,960 | 47,397 | 72.7 K to 47.4 K (-34.78 %) |
| Aug 28 2018 | NVCR | NovoCure Ltd | Palti Yoram | Chief Technology Of ... | Sell | S | 40.05 | 13,450 | 538,663 | 1,045,388 | 1.1 M to 1 M (-1.27 %) |
| Aug 28 2018 | NVCR | NovoCure Ltd | Palti Yoram | Chief Technology Of ... | Sell | S | 40.00 | 12,216 | 488,645 | 1,058,838 | 1.1 M to 1.1 M (-1.14 %) |
| Aug 24 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.67 | 31,179 | 1,174,603 | 72,671 | 103.9 K to 72.7 K (-30.02 %) |
| Aug 20 2018 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | J | 0.00 | 187,787 | 0 | 438,167 | 626 K to 438.2 K (-30.00 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.50 | 2,300 | 86,250 | 103,850 | 106.2 K to 103.9 K (-2.17 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.60 | 100 | 3,760 | 106,150 | 106.3 K to 106.2 K (-0.09 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.65 | 300 | 11,295 | 106,250 | 106.6 K to 106.3 K (-0.28 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.55 | 200 | 7,510 | 106,550 | 106.8 K to 106.6 K (-0.19 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.75 | 500 | 18,875 | 106,750 | 107.3 K to 106.8 K (-0.47 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.70 | 200 | 7,540 | 107,250 | 107.5 K to 107.3 K (-0.19 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.80 | 68 | 2,570 | 107,450 | 107.5 K to 107.5 K (-0.06 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 38.00 | 200 | 7,600 | 107,518 | 107.7 K to 107.5 K (-0.19 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.90 | 400 | 15,160 | 107,718 | 108.1 K to 107.7 K (-0.37 %) |
| Aug 16 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 37.85 | 100 | 3,785 | 108,118 | 108.2 K to 108.1 K (-0.09 %) |
| Aug 06 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 35.05 | 1,790 | 62,740 | 108,218 | 110 K to 108.2 K (-1.63 %) |
| Aug 06 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 35.00 | 5,336 | 186,760 | 110,008 | 115.3 K to 110 K (-4.63 %) |
| Aug 02 2018 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | A | 0.00 | 11,152 | 0 | 11,152 | |
| Aug 02 2018 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | A | 34.00 | 20,458 | 695,572 | 20,458 | |
| Aug 02 2018 | NVCR | NovoCure Ltd | HILLEMAN JERYL L | Director | Option Exercise | A | 34.00 | 37,101 | 1,261,434 | 37,101 | |
| Aug 02 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 35.05 | 100 | 3,505 | 115,344 | 115.4 K to 115.3 K (-0.09 %) |
| Aug 02 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 35.03 | 200 | 7,005 | 115,444 | 115.6 K to 115.4 K (-0.17 %) |
| Aug 02 2018 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 35.00 | 941 | 32,935 | 115,644 | 116.6 K to 115.6 K (-0.81 %) |